BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. JAMA Dermatol 2016;152:419-28. [PMID: 26762219 DOI: 10.1001/jamadermatol.2015.4994] [Cited by in Crossref: 190] [Cited by in F6Publishing: 174] [Article Influence: 31.7] [Reference Citation Analysis]
Number Citing Articles
1 Fujimura T, Aiba S. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers. Biomolecules 2020;10:E1087. [PMID: 32707850 DOI: 10.3390/biom10081087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Nelson TG, Ashton RE. Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event? J Surg Oncol 2017;116:783-8. [DOI: 10.1002/jso.24707] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gee HE, Veness MJ. High-Risk Cutaneous Squamous Cell Carcinoma. Curr Otorhinolaryngol Rep 2018;6:120-8. [DOI: 10.1007/s40136-018-0194-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cañueto J, Burguillo J, Moyano-Bueno D, Viñolas-Cuadros A, Conde-Ferreirós A, Corchete-Sánchez LA, Pérez-Losada J, Román-Curto C. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice. J Am Acad Dermatol 2019;80:106-113.e2. [PMID: 30003984 DOI: 10.1016/j.jaad.2018.06.060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
5 Roh E, Lee MH, Zykova TA, Zhu F, Nadas J, Kim HG, Bae KB, Li Y, Cho YY, Curiel-Lewandrowski C, Einspahr J, Dickinson SE, Bode AM, Dong Z. Targeting PRPK and TOPK for skin cancer prevention and therapy. Oncogene 2018;37:5633-47. [PMID: 29904102 DOI: 10.1038/s41388-018-0350-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
6 Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer 2017;123:2054-60. [PMID: 28171708 DOI: 10.1002/cncr.30601] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 13.2] [Reference Citation Analysis]
7 Cañueto J, Jaka A, Toll A. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review. Actas Dermosifiliogr (Engl Ed) 2018;109:476-84. [PMID: 29759308 DOI: 10.1016/j.ad.2018.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Dessinioti C, Platsidaki E, Stratigos AJ. A Sensitivity Meta-Analysis of Disease-Specific Death in Localized Cutaneous Squamous Cell Carcinoma. Dermatology 2022;:1-10. [PMID: 35550380 DOI: 10.1159/000524460] [Reference Citation Analysis]
9 Ibrahim SF, Kasprzak JM, Hall MA, Fitzgerald AL, Siegel JJ, Kurley SJ, Covington KR, Goldberg MS, Farberg AS, Trotter SC, Reed K, Brodland DG, Koyfman SA, Somani AK, Arron ST, Wysong A. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test. Future Oncol 2021. [PMID: 34821148 DOI: 10.2217/fon-2021-1277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kofler L. [Classification of cutaneous squamous cell carcinoma : How do I recognise my high-risk patient?]. Hautarzt 2019;70:870-4. [PMID: 31560082 DOI: 10.1007/s00105-019-04484-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Prezzano JC, Scott GA, Lambert Smith F, Mannava KA, Ibrahim SF. Concordance of Squamous Cell Carcinoma Histologic Grading Among Dermatopathologists and Mohs Surgeons. Dermatol Surg 2021;47:1433-7. [PMID: 34482328 DOI: 10.1097/DSS.0000000000003213] [Reference Citation Analysis]
12 Ashbaugh AG, Rotunda TD, Rotunda AM. Suicide After Mohs Surgery. Dermatol Surg 2021;47:547-9. [PMID: 33795574 DOI: 10.1097/DSS.0000000000002514] [Reference Citation Analysis]
13 Garcia J, Molinet E, Aponte CMC, Carlson A, Mulon P. A chronic, non‐healing, ulcerative and proliferative lesion revealed to be squamous cell carcinoma in a camel. Vet Record Case Reports. [DOI: 10.1002/vrc2.386] [Reference Citation Analysis]
14 Chen A, Ali N, Boasberg P, Ho AS. Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab. J Clin Med 2018;7:E10. [PMID: 29320468 DOI: 10.3390/jcm7010010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
15 Ascierto PA, Schadendorf D. Immunotherapy in non-melanoma skin cancer: updates and new perspectives. Drugs Context 2019;8:212583. [PMID: 30936937 DOI: 10.7573/dic.212583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
16 Gonzalez-guerrero M, Martínez-camblor P, Vivanco B, Fernández-vega I, Munguía-calzada P, Gonzalez-gutierrez MP, Rodrigo JP, Galache C, Santos-juanes J. The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma. Journal of the American Academy of Dermatology 2017;76:1139-45. [DOI: 10.1016/j.jaad.2017.01.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
17 Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data? Am J Dermatopathol 2020;42:337-42. [PMID: 31464719 DOI: 10.1097/DAD.0000000000001511] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Hartmann D, Ruzicka T, Flaig MJ, Antal AS. [Giant carcinoma of the face in the elderly - Hikikomori senectorum]. MMW Fortschr Med 2017;159:56-8. [PMID: 28321723 DOI: 10.1007/s15006-017-9392-0] [Reference Citation Analysis]
19 Arbab M, Margalit DN, Tishler RB, Rabinowits G, Pashtan IM, Borgelt BB, Powlis W, Holdsworth CH, Warren LE, Schoenfeld JD. Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence. Head Neck 2019;41:2111-5. [PMID: 30697925 DOI: 10.1002/hed.25663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Newman JG, Hall MA, Kurley SJ, Cook RW, Farberg AS, Geiger JL, Koyfman SA. Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review. Head Neck 2021;43:2822-43. [PMID: 34096664 DOI: 10.1002/hed.26767] [Reference Citation Analysis]
21 Diori Karidio I, Sanlier SH. Reviewing cancer's biology: an eclectic approach. J Egypt Natl Canc Inst 2021;33:32. [PMID: 34719756 DOI: 10.1186/s43046-021-00088-y] [Reference Citation Analysis]
22 Zhao G, Kim KY, Zheng Z, Oh Y, Yoo DS, Lee ME, Chung KY, Roh MR, Jin Z. AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery. Oncol Lett 2020;19:2133-40. [PMID: 32194711 DOI: 10.3892/ol.2020.11324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tam S, Yao CMKL, Amit M, Gajera M, Luo X, Treistman R, Khanna A, Aashiq M, Nagarajan P, Bell D, El-Naggar A, Migden M, Wong M, Glisson B, Ferrarotto R, Esmaeli B, Rosenthal D, Li G, Weber RS, Myers JN, Gross ND. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg 2020;146:128-35. [PMID: 31804658 DOI: 10.1001/jamaoto.2019.3751] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
24 Mousa AK, Elshenawy AA, Maklad SM, Bebars SMM, Burezq HA, Sayed SE. Post-burn scar malignancy: 5-year management review and experience. Int Wound J 2021. [PMID: 34535972 DOI: 10.1111/iwj.13690] [Reference Citation Analysis]
25 Waldman A, Schmults C. Cutaneous Squamous Cell Carcinoma. Hematol Oncol Clin North Am. 2019;33:1-12. [PMID: 30497667 DOI: 10.1016/j.hoc.2018.08.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 24.0] [Reference Citation Analysis]
26 Zou S, Gao Y, Zhang S. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma. Int J Oncol 2021;59:56. [PMID: 34195851 DOI: 10.3892/ijo.2021.5236] [Reference Citation Analysis]
27 Russo I, Fagotto L, Colombo A, Sartor E, Luisetto R, Alaibac M. Near-infrared photoimmunotherapy for the treatment of skin disorders. Expert Opin Biol Ther 2021;:1-9. [PMID: 34860146 DOI: 10.1080/14712598.2022.2012147] [Reference Citation Analysis]
28 Shapanis A, Lai C, Smith S, Coltart G, Sommerlad M, Schofield J, Parkinson E, Skipp P, Healy E. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs. Br J Dermatol 2021;184:709-21. [PMID: 32794257 DOI: 10.1111/bjd.19485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Willenbrink TJ, Jambusaria-Pahlajani A, Arron S, Seckin D, Harwood CA, Proby CM. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2019;33 Suppl 8:57-60. [PMID: 31833603 DOI: 10.1111/jdv.15843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Morandi EM, Rauchenwald T, Puelzl P, Zelger BW, Zelger BG, Henninger B, Pierer G, Wolfram D. Hide-and-seek: Neurotropic squamous cell carcinoma of the periorbital region - a series of five cases and review of the literature. J Dtsch Dermatol Ges 2021;19:1571-80. [PMID: 34811913 DOI: 10.1111/ddg.14582] [Reference Citation Analysis]
31 Rock AN, Fisher MD, Amborski G, Allain DC, Klee V, Peters SB, Kang S, Toland AE. MicroRNA Expression Profiling of Cutaneous Squamous Cell Carcinomas Arising in Different Sites. Otolaryngol Head Neck Surg 2020;163:538-45. [PMID: 32423289 DOI: 10.1177/0194599820918855] [Reference Citation Analysis]
32 Mull JL, Phelan PS, Mull AB, Russell AJ, Hurst EA, Council ML. Squamous Cell Carcinoma of the Hand: A Retrospective Study in Immunosuppressed and Immunocompetent Individuals. Dermatol Surg 2020;46:1014-20. [PMID: 32028479 DOI: 10.1097/DSS.0000000000002336] [Reference Citation Analysis]
33 Geidel G, Heidrich I, Kött J, Schneider SW, Pantel K, Gebhardt C. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma. NPJ Precis Oncol 2022;6:17. [PMID: 35322182 DOI: 10.1038/s41698-022-00261-z] [Reference Citation Analysis]
34 Riihilä P, Nissinen L, Knuutila J, Rahmati Nezhad P, Viiklepp K, Kähäri VM. Complement System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E3550. [PMID: 31331124 DOI: 10.3390/ijms20143550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
35 Schmitz L, Kanitakis J. Histological classification of cutaneous squamous cell carcinomas with different severity. J Eur Acad Dermatol Venereol 2019;33 Suppl 8:11-5. [PMID: 31833602 DOI: 10.1111/jdv.15950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Eigentler TK, Leiter U, Häfner H, Garbe C, Röcken M, Breuninger H. Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. Journal of Investigative Dermatology 2017;137:2309-15. [DOI: 10.1016/j.jid.2017.06.025] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
37 Munguía-Calzada P, Fernández-Vega I, Martínez-Camblor P, Díaz-Coto S, García-Pedrero JM, Vivanco B, Osuna CG, Vazquez-Lopez F, Rodrigo JP, Santos-Juanes J. Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma. Head Neck 2019;41:1290-6. [PMID: 30537291 DOI: 10.1002/hed.25556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Patel VA, McCullum C, Sparks AD, Schmults CD, Arron ST, Jambusaria-Pahlajani A. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study. Cancer Med 2021. [PMID: 34796670 DOI: 10.1002/cam4.4426] [Reference Citation Analysis]
39 Mooney CP, Clark JR, Shannon K, Palme CE, Ebrahimi A, Gao K, Ch'ng S, Elliott M, Gupta R, Low TH. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma. Head Neck 2021;43:2705-11. [PMID: 34019319 DOI: 10.1002/hed.26744] [Reference Citation Analysis]
40 Elahi M, Rakhshan V. MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma. Sci Rep 2020;10:8475. [PMID: 32439976 DOI: 10.1038/s41598-020-65145-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Totonchy MB, McNiff JM, Suozzi KC, Leffell DJ, Christensen SR. A Histopathologic Scoring System for Perineural Invasion Correlates With Adverse Outcomes in Patients With Cutaneous Squamous Cell Carcinoma. Dermatol Surg 2021;47:445-51. [PMID: 33795563 DOI: 10.1097/DSS.0000000000002923] [Reference Citation Analysis]
42 Haehl E, Rühle A, Klink R, Kalckreuth T, Sprave T, Gkika E, Zamboglou C, Meiß F, Grosu AL, Nicolay NH. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly. Radiat Oncol 2021;16:105. [PMID: 34118984 DOI: 10.1186/s13014-021-01832-3] [Reference Citation Analysis]
43 Wysong A, Newman JG, Covington KR, Kurley SJ, Ibrahim SF, Farberg AS, Bar A, Cleaver NJ, Somani AK, Panther D, Brodland DG, Zitelli J, Toyohara J, Maher IA, Xia Y, Bibee K, Griego R, Rigel DS, Meldi Plasseraud K, Estrada S, Sholl LM, Johnson C, Cook RW, Schmults CD, Arron ST. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2021;84:361-9. [PMID: 32344066 DOI: 10.1016/j.jaad.2020.04.088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Kyllo RL, Staser KW, Rosman I, Council ML, Hurst EA. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review. Journal of the American Academy of Dermatology 2019;81:541-7. [DOI: 10.1016/j.jaad.2019.02.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
45 Terra JB, Gaster MB, Halmos GB, Roodenburg JL, van der Vegt B, Romeijn TR, Bijl HP. Local control of 151 head and neck cutaneous squamous cell carcinoma after radiotherapy: a retrospective study on efficacy and prognostic factors. Clin Otolaryngol 2017;42:851-5. [PMID: 27423058 DOI: 10.1111/coa.12707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
46 Allen RC. Surgical Management of Periocular Cancers: High- and Low-Risk Features Drive Treatment. Curr Oncol Rep 2017;19:57. [PMID: 28735439 DOI: 10.1007/s11912-017-0618-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 Maeda T, Hiura A, Uehara J, Toyoshima R, Nakagawa T, Yoshino K. Neutrophil-to-lymphocyte ratio is associated with survival and sentinel lymph node positivity in invasive cutaneous squamous cell carcinoma: A retrospective study. J Am Acad Dermatol 2021:S0190-9622(21)02693-1. [PMID: 34715284 DOI: 10.1016/j.jaad.2021.10.033] [Reference Citation Analysis]
48 Fayne R, Nichols A, Vivas A. Squamous Cell Carcinoma with Perineural Invasion Presenting as a Prominent Follicular Opening. Am J Med 2020;133:e340-2. [PMID: 31874138 DOI: 10.1016/j.amjmed.2019.11.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Campos MA, Macedo S, Fernandes M, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma. J Am Acad Dermatol 2019;80:660-669.e6. [PMID: 30165166 DOI: 10.1016/j.jaad.2018.08.032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
50 Wilkie MD, Chudek DA, Flynn CD, Gaskell P, Loh C, Tandon S, Roland NJ, Jones TM, Lancaster J. Outcomes and prognosticators in regionally recurrent cutaneous squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2020;46:2035-41. [PMID: 32800595 DOI: 10.1016/j.ejso.2020.07.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Fernández-figueras M, Saenz-sardà X, Vargas P, Thompson C, Carrato C, Puig L, Ferrándiz C, Ariza A. The depth of follicular extension in actinic keratosis correlates with the depth of invasion in squamous cell carcinoma: implication for clinical treatment. J Eur Acad Dermatol Venereol 2018;32:1657-61. [DOI: 10.1111/jdv.14901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
52 Argenziano G, Fargnoli MC, Fantini F, Gattoni M, Gualdi G, Pastore F, Pellacani G, Quaglino P, Queirolo P, Troiani T. Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion. Ther Adv Med Oncol 2022;14:175883592110662. [DOI: 10.1177/17588359211066272] [Reference Citation Analysis]
53 Wilken R, Carucci J, Stevenson ML. Skin Cancers and Lung Transplant. Semin Respir Crit Care Med 2021;42:483-96. [PMID: 34030209 DOI: 10.1055/s-0041-1728798] [Reference Citation Analysis]
54 Leiter U, Gutzmer R, Alter M, Ulrich C, Meiwes A, Heppt MV, Steeb T, Berking C, Lonsdorf AS, Sachse MM, Garbe C, Hillen U. [Cutaneous squamous cell carcinoma]. Hautarzt 2020;71:597-606. [PMID: 32583034 DOI: 10.1007/s00105-020-04620-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Conde-ferreirós A, Corchete LA, Puebla-tornero L, Corchado-cobos R, García-sancha N, Román-curto C, Cañueto J. Definition of prognostic subgroups in the T3 stage of the eighth edition of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Tentative T3 stage subclassification. Journal of the American Academy of Dermatology 2020. [DOI: 10.1016/j.jaad.2020.03.088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Brambullo T, Azzena GP, Toninello P, Masciopinto G, De Lazzari A, Biffoli B, Vindigni V, Bassetto F. Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review. Front Oncol 2021;11:783257. [PMID: 34950589 DOI: 10.3389/fonc.2021.783257] [Reference Citation Analysis]
57 Upton M, Kita A, Scapa J, St John M. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma. Laryngoscope 2021;131:E170-5. [PMID: 32212346 DOI: 10.1002/lary.28633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Brugière C, El Bouchtaoui M, Leboeuf C, Gapihan G, Ait El Far R, Sy M, Lepage AL, Ratajczak P, Janin A, Verneuil L. Perineural Invasion in Human Cutaneous Squamous Cell Carcinoma Is Linked to Neurotrophins, Epithelial-Mesenchymal Transition, and NCAM1. J Invest Dermatol 2018;138:2063-6. [PMID: 29601811 DOI: 10.1016/j.jid.2018.02.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Swanson L, Kassab I, Tsung I, Worden FP, Fontana RJ. Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinoma. Immunotherapy 2022. [PMID: 35232282 DOI: 10.2217/imt-2021-0191] [Reference Citation Analysis]
60 Mahajan S, Barker CA, Singh B, Pandit-Taskar N. Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma. Nucl Med Commun 2019;40:744-51. [PMID: 31095044 DOI: 10.1097/MNM.0000000000001029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
61 Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, Bernabei R, Peris K. Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology. Aging Dis 2017;8:643-61. [PMID: 28966807 DOI: 10.14336/AD.2017.0503] [Cited by in Crossref: 66] [Cited by in F6Publishing: 32] [Article Influence: 13.2] [Reference Citation Analysis]
62 Tolkachjov SN, Brodland DG, Coldiron BM, Fazio MJ, Hruza GJ, Roenigk RK, Rogers HW, Zitelli JA, Winchester DS, Harmon CB. Understanding Mohs Micrographic Surgery: A Review and Practical Guide for the Nondermatologist. Mayo Clin Proc 2017;92:1261-71. [PMID: 28778259 DOI: 10.1016/j.mayocp.2017.04.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
63 Wang DM, Kraft S, Rohani P, Murphy GF, Besaw RJ, Karia PS, Morgan FC, Schmults CD. Association of Nodal Metastasis and Mortality With Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the Lip. JAMA Dermatol 2018;154:701-7. [PMID: 29801066 DOI: 10.1001/jamadermatol.2018.0792] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
64 Kofler L, Kofler K, Schulz C, Breuninger H, Häfner HM. Sentinel lymph node biopsy for high-thickness cutaneous squamous cell carcinoma. Arch Dermatol Res 2021;313:119-26. [PMID: 32385689 DOI: 10.1007/s00403-020-02082-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Nelson R, Luu L, Silberstein P, Velagapudi M, Huerter C. Novel treatment of locally advanced cutaneous squamous cell carcinoma with cemiplimab: a case report. Int J Dermatol 2021;60:233-5. [PMID: 32955136 DOI: 10.1111/ijd.15176] [Reference Citation Analysis]
66 Dessinioti C, Pitoulias M, Stratigos AJ. Epidemiology of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2021. [PMID: 34592000 DOI: 10.1111/jdv.17709] [Reference Citation Analysis]
67 Ciuciulete AR, Stepan AE, Andreiana BC, Simionescu CE. Clinicopathological Correlations in Cutaneous Squamous Cell Carcinomas. Curr Health Sci J 2021;47:61-7. [PMID: 34211749 DOI: 10.12865/CHSJ.47.01.10] [Reference Citation Analysis]
68 Barthelemy I. [Therapeutic failure in skin carcinomas of the face]. Ann Chir Plast Esthet 2019;64:552-60. [PMID: 31128865 DOI: 10.1016/j.anplas.2019.04.003] [Reference Citation Analysis]
69 Grob JJ, Gonzalez R, Basset-Seguin N, Vornicova O, Schachter J, Joshi A, Meyer N, Grange F, Piulats JM, Bauman JR, Zhang P, Gumuscu B, Swaby RF, Hughes BGM. Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629). J Clin Oncol 2020;38:2916-25. [PMID: 32673170 DOI: 10.1200/JCO.19.03054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
70 Sahovaler A, Krishnan RJ, Yeh DH, Zhou Q, Palma D, Fung K, Yoo J, Nichols A, MacNeil SD. Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg 2019;145:352-60. [PMID: 30844021 DOI: 10.1001/jamaoto.2018.4515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
71 Reynolds KA, Schlessinger DI, Yanes AF, Godinez-Puig V, Chen BR, Kurta AO, Cotseones JK, Chiren SG, Iyengar S, Ibrahim SA, Kang BY, Worley B, Behshad R, DeHoratius DM, Denes P, Drucker AM, Dzubow LM, Etzkorn JR, Harwood CA, Kim JYS, Lawrence N, Lee EH, Lissner GS, Marghoob AA, Guminiski A, Matin RN, Mattox AR, Mittal BB, Thomas JR, Zhou XA, Zloty D, Hughes BGM, Nottage MK, Green AC, Testori AAE, Argenziano G, Longo C, Zalaudek I, Lebbe C, Malvehy J, Saiag P, Cernea SS, Schmitt J, Kirkham JJ, Poon E, Sobanko JF, Cartee TV, Maher IA, Alam M. Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes. Br J Dermatol 2021;184:1113-22. [PMID: 33236347 DOI: 10.1111/bjd.19693] [Reference Citation Analysis]
72 Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Fargnoli MC, Forsea AM, Frenard C, Harwood CΑ, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer 2020;128:60-82. [PMID: 32113941 DOI: 10.1016/j.ejca.2020.01.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
73 Yom SS. Integrating the Management of Nodal Metastasis Into the Treatment of Nonmelanoma Skin Cancer. Seminars in Radiation Oncology 2019;29:171-9. [DOI: 10.1016/j.semradonc.2018.11.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 de Jong E, Lammerts MUPA, Genders RE, Bouwes Bavinck JN. Update of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2022;36 Suppl 1:6-10. [PMID: 34855246 DOI: 10.1111/jdv.17728] [Reference Citation Analysis]
75 Domínguez-Cherit J, Rodríguez-Gutiérrez G, Narváez Rosales V, Toussaint Caire S, Fonte Avalos V. [Characteristics and risk factors for recurrence of cutaneous squamous cell carcinoma with conventional surgery and surgery with delayed intraoperative margin assessment]. Cir Cir 2017;85:499-503. [PMID: 28087048 DOI: 10.1016/j.circir.2016.11.013] [Reference Citation Analysis]
76 Hennequin C, Rio E, Quéro L, Clavère P. Radiation therapy of cutaneous cancers. Cancer Radiother 2021:S1278-3218(21)00310-3. [PMID: 34955421 DOI: 10.1016/j.canrad.2021.11.020] [Reference Citation Analysis]
77 Stevenson ML, Criscito MC, Wilken R, Doudican NA, Bain EE 3rd, Parashar B, Carucci JA. Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion. JAMA Dermatol 2020;156:918-21. [PMID: 32609298 DOI: 10.1001/jamadermatol.2020.1984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
78 Stiff KM, Jellinek N, Knackstedt TJ. A Call for Evidence-Based Conservative Management of Nail Unit Malignancies. Plast Reconstr Surg 2022. [PMID: 35157617 DOI: 10.1097/PRS.0000000000008968] [Reference Citation Analysis]
79 McIlwee BE, Abidi NY, Ravi M, Carr DR. Utility of Debulk Specimens During Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma. Dermatol Surg 2021;47:599-604. [PMID: 33587374 DOI: 10.1097/DSS.0000000000002932] [Reference Citation Analysis]
80 Dong Y, Fu C, Guan H, Zhang Z, Zhou T, Li B. Prognostic significance of miR-126 in various cancers: a meta-analysis. Onco Targets Ther 2016;9:2547-55. [PMID: 27217773 DOI: 10.2147/OTT.S103481] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
81 Xue J, Chen W, Xu W, Xu Z, Li X, Qi F, Wang Z. Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis. Cancer Med 2021;10:173-87. [PMID: 33247630 DOI: 10.1002/cam4.3596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
82 Kiely J, Kostusiak M, Bloom O, Roshan A. Poorly differentiated cutaneous squamous cell carcinomas have high incomplete excision rates with UK minimum recommended pre-determined surgical margins. J Plast Reconstr Aesthet Surg 2020;73:43-52. [PMID: 31473117 DOI: 10.1016/j.bjps.2019.06.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
83 Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer 2020;8:e000347. [PMID: 32188704 DOI: 10.1136/jitc-2019-000347] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 31.0] [Reference Citation Analysis]
84 Bander TS, Nehal KS, Lee EH. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management. Dermatol Clin 2019;37:241-51. [PMID: 31084718 DOI: 10.1016/j.det.2019.03.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
85 Pyne JH, Myint E, Clark SP, Gorji M, Hou R. Early Squamous Cell Carcinoma With Perineural Invasion: A Prospective Study Examining Anatomic Site, Tumor Surface Diameter, Invasion Depth, and Grade of Differentiation in 1,772 Consecutive Cases. Dermatol Pract Concept 2020;10:e2020059. [PMID: 32642309 DOI: 10.5826/dpc.1003a59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Zhang J, Wang Y, Wijaya WA, Liang Z, Chen J. Efficacy and prognostic factors of adjuvant radiotherapy for cutaneous squamous cell carcinoma: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2021;35:1777-87. [PMID: 33930213 DOI: 10.1111/jdv.17330] [Reference Citation Analysis]
87 Tremblay-Abel V, Poulin MA, Blouin MM, Parent F, Perron É. Sentinel Lymph Node Biopsy in High-Risk Cutaneous Squamous Cell Carcinoma: Analysis of a Large Size Retrospective Series. Dermatol Surg 2021;47:908-13. [PMID: 33988549 DOI: 10.1097/DSS.0000000000003085] [Reference Citation Analysis]
88 He W, Mao T, Yan J, Leng X, Deng X, Xie Q, Peng L, Liao Q, Scarpa M, Han Y. Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy. Ann Transl Med 2021;9:706. [PMID: 33987404 DOI: 10.21037/atm-21-1815] [Reference Citation Analysis]
89 Luo M, Shi L, Zhang F, Zhou F, Zhang L, Wang B, Wang P, Zhang Y, Zhang H, Yang D, Zhang G, Chen WR, Wang X. Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity. Int J Hyperthermia 2018;34:1337-50. [PMID: 29482392 DOI: 10.1080/02656736.2018.1446221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
90 Janus JM, O'Shaughnessy RFL, Harwood CA, Maffucci T. Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas. Cancers (Basel) 2017;9:E86. [PMID: 28696382 DOI: 10.3390/cancers9070086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
91 Cañueto J, Tejera-Vaquerizo A, Redondo P, Botella-Estrada R, Puig S, Sanmartin O. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis. Actas Dermosifiliogr (Engl Ed) 2020;111:281-90. [PMID: 32359704 DOI: 10.1016/j.ad.2019.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
92 Unsal AA, Unsal AB, Henn TE, Baredes S, Eloy JA. Cutaneous squamous cell carcinoma of the lip: A population-based analysis: Cutaneous Squamous Cell Carcinoma of the Lip. The Laryngoscope 2018;128:84-90. [DOI: 10.1002/lary.26704] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
93 Eviston TJ, Minaei E, Mueller SA, Ahmadi N, Ashford B, Clark JR, West N, Zhang P, Gupta R, Ranson M. Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma. Sci Rep 2021;11:13192. [PMID: 34162930 DOI: 10.1038/s41598-021-92335-4] [Reference Citation Analysis]
94 Gonçalves Ferreira I, Boff AL, Luzzato L, Martins Souza PR, Bevilaqua M. Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter? Dermatol Pract Concept 2021;11:e2021034. [PMID: 33954017 DOI: 10.5826/dpc.1102a34] [Reference Citation Analysis]
95 Yan G, Li L, Zhu S, Wu Y, Liu Y, Zhu L, Zhao Z, Wu F, Jia N, Liao C, Jiang L, Zeng Q, Wang P, Shi L, Zheng Z, Fang S, Zhang G, Tang Y, Wang X. Single-cell transcriptomic analysis reveals the critical molecular pattern of UV-induced cutaneous squamous cell carcinoma. Cell Death Dis 2022;13. [DOI: 10.1038/s41419-021-04477-y] [Reference Citation Analysis]
96 Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy. Head & Neck 2018;40:1406-14. [DOI: 10.1002/hed.25114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
97 Taylor JM, Dasgeb B, Liem S, Ali A, Harrison A, Finkelstein M, Cha J, Anne R, Greenbaum S, Sherwin W, Shi W. High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinomas on Sensitive Areas of the Face: A Report of Clinical Outcomes and Acute and Subacute Toxicities. Adv Radiat Oncol 2021;6:100616. [PMID: 33912732 DOI: 10.1016/j.adro.2020.10.028] [Reference Citation Analysis]
98 Damiani G, Grossi E, Berti E, Conic RRZ, Radhakrishna U, Pacifico A, Bragazzi NL, Piccinno R, Linder D. Artificial neural networks allow response prediction in squamous cell carcinoma of the scalp treated with radiotherapy. J Eur Acad Dermatol Venereol 2020;34:1369-73. [PMID: 31968143 DOI: 10.1111/jdv.16210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Tian J, Shen R, Yan Y, Deng L. miR-186 promotes tumor growth in cutaneous squamous cell carcinoma by inhibiting apoptotic protease activating factor-1. Exp Ther Med 2018;16:4010-8. [PMID: 30344679 DOI: 10.3892/etm.2018.6679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
100 Polcz MM, Sebaratnam DF, Fernández-peñas P. Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death. Australas J Dermatol 2018;59:10-25. [DOI: 10.1111/ajd.12646] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
101 Tschetter AJ, Campoli MR, Zitelli JA, Brodland DG. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study. Journal of the American Academy of Dermatology 2020;82:139-48. [DOI: 10.1016/j.jaad.2019.06.1303] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
102 Haisma MS, Plaat BE, Bijl HP, Roodenburg JL, Diercks GF, Romeijn TR, Terra JB. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck. Journal of the American Academy of Dermatology 2016;75:722-30. [DOI: 10.1016/j.jaad.2016.06.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
103 Lanz J, Bouwes Bavinck JN, Westhuis M, Quint KD, Harwood CA, Nasir S, Van-de-Velde V, Proby CM, Ferrándiz C, Genders RE, Del Marmol V, Forchetti G, Hafner J, Vital DG, Hofbauer GFL. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients. JAMA Dermatol 2019;155:66-71. [PMID: 30516812 DOI: 10.1001/jamadermatol.2018.4406] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
104 Blechman AB, Carucci JA, Stevenson ML. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems. Dermatol Surg 2019;45:1117-24. [DOI: 10.1097/dss.0000000000001774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
105 Baum CL, Wright AC, Martinez JC, Arpey CJ, Brewer JD, Roenigk RK, Otley CC. A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management. J Am Acad Dermatol 2018;78:141-7. [PMID: 28917382 DOI: 10.1016/j.jaad.2017.07.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
106 Mooney CP, Martin RCW, Dirven R, Ashford BG, Shannon K, Palme CE, Ngo Q, Wykes J, Davies S, Gao K, Ch’ng S, Low T, Gupta R, Clark JR. Sentinel Node Biopsy in 105 High-Risk Cutaneous SCCs of the Head and Neck: Results of a Multicenter Prospective Study. Ann Surg Oncol 2019;26:4481-8. [DOI: 10.1245/s10434-019-07865-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
107 Sato Y, Fujimura T, Kambayashi Y, Tsukada A, Hidaka T, Tanita K, Haga T, Hashimoto A, Aiba S. Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile Dermatomyositis. Case Rep Oncol 2017;10:106-11. [PMID: 28203172 DOI: 10.1159/000456001] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
108 Parekh V, Seykora JT. Cutaneous Squamous Cell Carcinoma. Clin Lab Med 2017;37:503-25. [PMID: 28802498 DOI: 10.1016/j.cll.2017.06.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
109 Gundogan B, Dowlut N, Rajmohan S, Borrelli MR, Millip M, Iosifidis C, Udeaja YZ, Mathew G, Fowler A, Agha R. Assessing the compliance of systematic review articles published in leading dermatology journals with the PRISMA statement guidelines: A systematic review. JAAD Int 2020;1:157-74. [PMID: 34409336 DOI: 10.1016/j.jdin.2020.07.007] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
110 Lederhandler M, Stokar E, Meehan SA, Geronemus RG. Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor. J Am Acad Dermatol 2020;82:e129-30. [PMID: 31836558 DOI: 10.1016/j.jaad.2019.12.007] [Reference Citation Analysis]
111 Muto P, Pastore F. Radiotherapy in the Adjuvant and Advanced Setting of CSCC. Dermatol Pract Concept 2021;11:e2021168S. [PMID: 34877076 DOI: 10.5826/dpc.11S2a168S] [Reference Citation Analysis]
112 Piipponen M, Riihilä P, Nissinen L, Kähäri VM. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4507. [PMID: 34572732 DOI: 10.3390/cancers13184507] [Reference Citation Analysis]
113 Wang Y, Sun B, Wen X, Hao D, Du D, He G, Jiang X. The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma. Front Oncol 2020;10:158. [PMID: 32185124 DOI: 10.3389/fonc.2020.00158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
114 Reise-Filteau M, Carter M, DeCoste R, Kohansal A. Metastasis of cutaneous squamous cell carcinoma to the stomach: a rare entity. BMJ Case Rep 2020;13:e238731. [PMID: 33257393 DOI: 10.1136/bcr-2020-238731] [Reference Citation Analysis]
115 Leigh IM. Advanced cutaneous squamous cell carcinoma - a pressing case for treatment. J Eur Acad Dermatol Venereol 2019;33 Suppl 8:3-5. [PMID: 31833611 DOI: 10.1111/jdv.15841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Trosman SJ, Zhu A, Nicolli EA, Leibowitz JM, Sargi ZB. High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant Treatment. Laryngoscope 2021;131:E136-43. [PMID: 32065413 DOI: 10.1002/lary.28564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Maly CJ, Cumsky HJL, Costello CM, Schmidt JE, Butterfield RJ, Zhang N, DiCaudo DJ, Nelson SA, Smith ML, Ochoa SA, Baum CL, Nagel TH, Pittelkow MR, Sekulic A, Mangold AR. Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma. J Am Acad Dermatol 2020;82:846-53. [PMID: 31437542 DOI: 10.1016/j.jaad.2019.08.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
118 Tobin DJ. Unpicking the Gordian knot of identifying metastasis development-relevant proteins in cutaneous squamous cell carcinoma. Br J Dermatol 2021;184:593. [PMID: 33325538 DOI: 10.1111/bjd.19697] [Reference Citation Analysis]
119 Heerfordt IM. Decreased public awareness of skin cancer during the coronavirus pandemic. Int J Dermatol 2021;60:e334-5. [PMID: 33982801 DOI: 10.1111/ijd.15659] [Reference Citation Analysis]
120 Thiem DGE, Scharr K, Pabst AM, Saka B, Kämmerer PW. Facial cutaneous squamous cell carcinoma - microscopic safety margins and their impact on developing local recurrences. J Craniomaxillofac Surg 2020;48:49-55. [PMID: 31810842 DOI: 10.1016/j.jcms.2019.11.022] [Reference Citation Analysis]
121 Droll S, Bao X. Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma. Cell Physiol Biochem 2021;55:89-119. [PMID: 34553848 DOI: 10.33594/000000433] [Reference Citation Analysis]
122 Köhler F, Rodríguez-Paredes M. DNA Methylation in Epidermal Differentiation, Aging, and Cancer. J Invest Dermatol 2020;140:38-47. [PMID: 31427190 DOI: 10.1016/j.jid.2019.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
123 Sato Y, Fujimura T, Hidaka T, Lyu C, Tanita K, Matsushita S, Yamamoto M, Aiba S. Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma. Front Immunol 2020;11:534323. [PMID: 33178182 DOI: 10.3389/fimmu.2020.534323] [Reference Citation Analysis]
124 In GK, Vaidya P, Filkins A, Hermel DJ, King KG, Ragab O, Tseng WW, Swanson M, Kokot N, Lang JE, Menendez L, DeClerck B, Kim G, Hu JC, Terando A, Jadvar H, Ricker C, Miller KA, Peng DH, Wysong A. PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. J Cancer Res Clin Oncol 2021;147:1803-11. [PMID: 33210210 DOI: 10.1007/s00432-020-03458-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Li ZX, Huang ZN, Luo H, Yang XB, Wang YL, Chen JX, Ma XK, Xu F, Wang TT, Lin L. High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer. Ann Transl Med 2021;9:1252. [PMID: 34532389 DOI: 10.21037/atm-21-3409] [Reference Citation Analysis]
126 Skulsky SL, O'sullivan B, Mcardle O, Leader M, Roche M, Conlon PJ, O'neill JP, W. Eisele D. Review of high‐risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck 2017;39:578-94. [DOI: 10.1002/hed.24580] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
127 Zhang X, Wu L, Xiao T, Tang L, Jia X, Guo Y, Zhang J, Li J, He Y, Su J, Zhao S, Tao J, Zhou J, Chen X, Peng C. TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR. Oncogenesis 2018;7:17. [PMID: 29463844 DOI: 10.1038/s41389-018-0030-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
128 Wollina U, Krönert C, Schönlebe J, Vojvodic A, Lotti T. Giant Squamous Cell Carcinoma on Chronic Lichen Planus on the Ankle - A Case Report and Short Literature Review. Open Access Maced J Med Sci 2019;7:3061-3. [PMID: 31850123 DOI: 10.3889/oamjms.2019.553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
129 Farberg AS, Hall MA, Douglas L, Covington KR, Kurley SJ, Cook RW, Dinehart SM. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management. Curr Med Res Opin 2020;36:1301-7. [PMID: 32351136 DOI: 10.1080/03007995.2020.1763284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
130 Brauer PR, Reddy CA, Ku JA, Prendes BL, Lamarre ED. Does neck dissection affect post-operative outcomes in parotidectomy? A national study. Am J Otolaryngol 2020;41:102593. [PMID: 32521296 DOI: 10.1016/j.amjoto.2020.102593] [Reference Citation Analysis]
131 Rabinowits G, Migden MR, Schlesinger TE, Ferris RL, Freeman M, Guild V, Koyfman S, Pavlick AC, Swanson N, Wolf GT, Dinehart SM. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. JID Innov 2021;1:100045. [PMID: 34909742 DOI: 10.1016/j.xjidi.2021.100045] [Reference Citation Analysis]
132 Wu S, Slater NA, Sayed CJ, Googe PB. PD‐L1 and LAG ‐3 expression in advanced cutaneous squamous cell carcinomas. J Cutan Pathol 2020;47:882-7. [DOI: 10.1111/cup.13709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Holmes TR, Al Matouq J, Holmes M, Sioda N, Rudd JC, Bloom C, Nicola L, Palermo NY, Madson JG, Lovas S, Hansen LA. Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma. Carcinogenesis 2021;42:232-42. [PMID: 32816038 DOI: 10.1093/carcin/bgaa091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Morandi EM, Rauchenwald T, Puelzl P, Zelger BW, Zelger BG, Henninger B, Pierer G, Wolfram D. Hide-and-seek: Neurotropes Plattenepithelkarzinom der periorbitalen Region - eine Fallserie und Übersichtsarbeit aktueller Literatur. J Dtsch Dermatol Ges 2021;19:1571-81. [PMID: 34811899 DOI: 10.1111/ddg.14582_g] [Reference Citation Analysis]
135 Knackstedt TJ, Knackstedt RW, Djohan M, Djohan R, Gastman BR, Crowe DR. New Developments in the Management of Cutaneous Squamous Cell Carcinoma. Plast Reconstr Surg 2021;147:492-504. [PMID: 33620947 DOI: 10.1097/PRS.0000000000007678] [Reference Citation Analysis]
136 Fang S, Wu Y, Zhang H, Zeng Q, Wang P, Zhang L, Yan G, Zhang G, Wang X. Molecular characterization of gene expression changes in murine cutaneous squamous cell carcinoma after 5-aminolevulinic acid photodynamic therapy. Photodiagnosis and Photodynamic Therapy 2022. [DOI: 10.1016/j.pdpdt.2022.102907] [Reference Citation Analysis]
137 Cañueto J, Jaka A, Toll A. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review. Actas Dermo-Sifiliográficas (English Edition) 2018;109:476-84. [DOI: 10.1016/j.adengl.2018.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Bode AM, Roh E. Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer? Cells 2020;9:E1674. [PMID: 32664608 DOI: 10.3390/cells9071674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Grammatica A, Tomasoni M, Fior M, Ulaj E, Gualtieri T, Bossi P, Battocchio S, Lombardi D, Deganello A, Mattavelli D, Nicolai P, Girardi F, Piazza C. Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases. Eur Arch Otorhinolaryngol 2021. [PMID: 34170382 DOI: 10.1007/s00405-021-06944-w] [Reference Citation Analysis]
140 Han AY, John MAS. Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers. Curr Oncol Rep 2022. [PMID: 35394247 DOI: 10.1007/s11912-022-01249-5] [Reference Citation Analysis]
141 Bibee K, Swartz A, Sridharan S, Kurten CHL, Wessel CB, Skinner H, Zandberg DP. Cutaneous squamous cell carcinoma in the organ transplant recipient. Oral Oncol 2020;103:104562. [PMID: 32065978 DOI: 10.1016/j.oraloncology.2019.104562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Xu YG, Aylward JL, Swanson AM, Spiegelman VS, Vanness ER, Teng JM, Snow SN, Wood GS. Nonmelanoma Skin Cancers. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1052-1073.e8. [DOI: 10.1016/b978-0-323-47674-4.00067-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Amit M, Liu C, Gleber-Netto FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Baruch EN, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer 2021;127:1238-45. [PMID: 33320343 DOI: 10.1002/cncr.33373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Campos MA, Macedo S, Fernandes MS, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas. Genes (Basel) 2020;11:E751. [PMID: 32640663 DOI: 10.3390/genes11070751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
145 Feinstein S, Higgins S, Ahadiat O, Wysong A. A Retrospective Cohort Study of Cutaneous Squamous Cell Carcinoma With Lymph Node Metastasis: Risk Factors and Clinical Course. Dermatol Surg 2019;45:772-81. [DOI: 10.1097/dss.0000000000001828] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
146 Bauer C, Abdul Pari AA, Umansky V, Utikal J, Boukamp P, Augustin HG, Goerdt S, Géraud C, Felcht M. T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin. Cancer Immunol Immunother 2018;67:1147-57. [PMID: 29799076 DOI: 10.1007/s00262-018-2171-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
147 Haug K, Breuninger H, Metzler G, Eigentler T, Eichner M, Häfner HM, Schnabl SM. Prognostic Impact of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Results of a Prospective Study of 1,399 Tumors. J Invest Dermatol 2020;140:1968-75. [PMID: 32169476 DOI: 10.1016/j.jid.2020.01.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
148 Mcdowell L, Yom SS. Locally advanced non-melanomatous skin cancer: Contemporary radiotherapeutic management. Oral Oncology 2019;99:104443. [DOI: 10.1016/j.oraloncology.2019.104443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
149 Bergón-sendín M, Pulido-pérez A, Carretero López F, Díez-sebastián J, Suárez-fernández R. Cutaneous Ultrasound for Tumor Thickness Measurement in Squamous Cell Carcinoma: The Effect of Neoadjuvant Intralesional Methotrexate in 40 Patients. Dermatol Surg 2020;46:530-6. [DOI: 10.1097/dss.0000000000002139] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
150 Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities. Clin Cancer Res 2019;25:2379-91. [PMID: 30523023 DOI: 10.1158/1078-0432.CCR-18-1122] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 10.3] [Reference Citation Analysis]
151 Yan F, Tillman BN, Nijhawan RI, Srivastava D, Sher DJ, Avkshtol V, Homsi J, Bishop JA, Wynings EM, Lee R, Myers LL, Day AT. High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review. Ann Surg Oncol 2021. [PMID: 34195900 DOI: 10.1245/s10434-021-10108-9] [Reference Citation Analysis]
152 Bailey A, Vasicek B, Tao J, Janeczek M, Mitri A, Tung R. Management of keratinocyte carcinoma - Special considerations in the elderly. Int J Womens Dermatol 2019;5:235-45. [PMID: 31700979 DOI: 10.1016/j.ijwd.2019.05.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Burton KA, Ashack KA, Khachemoune A. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am J Clin Dermatol 2016;17:491-508. [PMID: 27358187 DOI: 10.1007/s40257-016-0207-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 22.8] [Reference Citation Analysis]
154 Jubran J, Sengelmann RD. High-risk squamous cell carcinoma and its impact on a 62-year-old male surgeon. BMJ Case Rep 2019;12:e229940. [PMID: 31471358 DOI: 10.1136/bcr-2019-229940] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
155 Zhang G, Yan G, Fu Z, Wu Y, Wu F, Zheng Z, Fang S, Gao Y, Bao X, Liu Y, Wang X, Zhu S. Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC. Cell Death Dis 2021;12:247. [PMID: 33664254 DOI: 10.1038/s41419-021-03525-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
156 Luo Y, Chen H, Ge S, Rao Y, Yu J, Fan X, Jia R, Xu S, Wang Y. Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma. Br J Ophthalmol 2021:bjophthalmol-2020-317546. [PMID: 33879470 DOI: 10.1136/bjophthalmol-2020-317546] [Reference Citation Analysis]
157 Brancaccio G, Briatico G, Pellegrini C, Rocco T, Moscarella E, Fargnoli MC. Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma. Dermatol Pract Concept 2021;11:e2021166S. [PMID: 34877074 DOI: 10.5826/dpc.11S2a166S] [Reference Citation Analysis]
158 Cohen ER, Misztal C, Dable C, Gomez-Fernandez C, Bhatia RG, Roth P, Ma R, Trosman S, Green C, Nicolli E, Dinh CT, Sargi ZB. Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2022;:1945998221076110. [PMID: 35133896 DOI: 10.1177/01945998221076110] [Reference Citation Analysis]
159 Wach MM, van Beek E, Ayabe R, Ruff S, Brown Z, Goldman DA, Zambirinis CP, Gholami S, Pulitzer M, Hernandez J, Coit D. Metastatic squamous cell carcinoma of known and unknown primary origin treated with axillary or inguinal lymphadenectomy. Am J Surg 2018;216:963-8. [PMID: 30143231 DOI: 10.1016/j.amjsurg.2018.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
160 Venables ZC. Icelandic study of cutaneous squamous cell carcinoma (cSCC) epidemiology highlights the worldwide burden of disease and challenges of in situ and invasive cSCC registry data. Br J Dermatol 2021;185:477-8. [PMID: 34060067 DOI: 10.1111/bjd.20422] [Reference Citation Analysis]
161 Caley MP, Martins VL, Moore K, Lashari M, Nissinen L, Kähäri VM, Alexander S, Jones E, Harwood CA, Jones J, Donaldson M, Marshall JF, O'Toole EA. Loss of the laminin subunit alpha-3 induces cell invasion and macrophage infiltration in cutaneous squamous cell carcinoma. Br J Dermatol 2021;184:923-34. [PMID: 32767748 DOI: 10.1111/bjd.19471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
162 Leiter U, Gutzmer R, Alter M, Ulrich C, Lonsdorf AS, Sachse MM, Hillen U. [Cutaneous squamous cell carcinoma]. Hautarzt 2016;67:857-66. [PMID: 27680009 DOI: 10.1007/s00105-016-3875-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
163 Breuninger H, Eigentler T, Häfner HM, Leiter U. Local surgical treatment of cutaneous squamous cell carcinoma: deficits and controversies in the literature. J Dtsch Dermatol Ges 2019;17:999-1004. [PMID: 31545559 DOI: 10.1111/ddg.13941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 Almadori G, De Corso E, Settimi S, Di Cintio G, Mele DA, Brigato F, Paludetti G, Salgarello M. When is a surgical multidisciplinary approach required in the management of head and neck non-melanoma skin cancer and in advanced head and neck pathologies involving skin? Acta Otorhinolaryngol Ital 2021;41:S145-57. [PMID: 34060530 DOI: 10.14639/0392-100X-suppl.1-41-2021-15] [Reference Citation Analysis]
165 Mahajan S, Barker CA, Mauguen A, Singh B, Pandit-Taskar N. Restaging [18F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significance. J Am Acad Dermatol 2020;82:878-86. [PMID: 31562942 DOI: 10.1016/j.jaad.2019.09.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
166 Cañueto J, Jaka A, Corchete L, González‐pérez A, García‐castro R, Fuente M, Membrive I, March Á, Mañes A, Posada R, Pujol R, Román‐curto C, Toll A. Postoperative radiotherapy provides better local control and long‐term outcome in selective cases of cutaneous squamous cell carcinoma with perineural invasion. J Eur Acad Dermatol Venereol 2020;34:1080-91. [DOI: 10.1111/jdv.16001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
167 Quéro L, Fumagalli I, Benadon B, Mignot F, Guillerm S, Labidi M, Hennequin C. [Place of radiotherapy in the treatment of cutaneous carcinomas]. Cancer Radiother 2021:S1278-3218(21)00158-X. [PMID: 34400089 DOI: 10.1016/j.canrad.2021.07.006] [Reference Citation Analysis]
168 Bigge B, Ungerechts G, Bigge S. Photodynamic therapy and laser‐assisted drug delivery and R0 excision in the treatment of an immunosuppressed patient showing multiple actinic keratosis and recurrent squamous cell carcinoma: A case report. Translational Biophotonics 2020;2. [DOI: 10.1002/tbio.201900037] [Reference Citation Analysis]
169 Villani A, Potestio L, Fabbrocini G, Scalvenzi M. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma. Adv Ther 2022. [PMID: 35089534 DOI: 10.1007/s12325-022-02044-1] [Reference Citation Analysis]
170 van Kester MS, Genders RE, Quint KD. Lymphangitis carcinomatosa of a cutaneous squamous cell carcinoma. BMJ Case Rep 2018;2018:bcr-2017-222923. [PMID: 29437807 DOI: 10.1136/bcr-2017-222923] [Reference Citation Analysis]
171 Sarin KY, Lin Y, Daneshjou R, Ziyatdinov A, Thorleifsson G, Rubin A, Pardo LM, Wu W, Khavari PA, Uitterlinden A, Nijsten T, Toland AE, Olafsson JH, Sigurgeirsson B, Thorisdottir K, Jorgensen E, Whittemore AS, Kraft P, Stacey SN, Stefansson K, Asgari MM, Han J. Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nat Commun 2020;11:820. [PMID: 32041948 DOI: 10.1038/s41467-020-14594-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
172 Flukes S, Long S, Lohia S, Barker CA, Dunn LA, Cracchiolo J, Ganly I, Patel S, Cohen MA. Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt. OTO Open 2021;5:2473974X20984720. [PMID: 33474523 DOI: 10.1177/2473974X20984720] [Reference Citation Analysis]
173 Stanganelli I, Spagnolo F, Argenziano G, Ascierto PA, Bassetto F, Bossi P, Donato V, Massi D, Massone C, Patuzzo R, Pellacani G, Quaglino P, Queirolo P, Zalaudek I, Palmieri G; on behalf of Italian Melanoma Intergroup (IMI). The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts. Cancers 2022;14:377. [DOI: 10.3390/cancers14020377] [Reference Citation Analysis]
174 Boutros A, Cecchi F, Tanda ET, Croce E, Gili R, Arecco L, Spagnolo F, Queirolo P. Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma. Front Oncol 2021;11:733917. [PMID: 34513710 DOI: 10.3389/fonc.2021.733917] [Reference Citation Analysis]
175 Rogers EM, Connolly KL, Nehal KS, Dusza SW, Rossi AM, Lee E. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer. J Am Acad Dermatol 2018;78:1119-24. [PMID: 29288096 DOI: 10.1016/j.jaad.2017.12.048] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
176 Farberg AS, Fitzgerald AL, Ibrahim SF, Tolkachjov SN, Soleymani T, Douglas LM, Kurley SJ, Arron ST. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review. Dermatol Ther (Heidelb) 2022. [PMID: 34994967 DOI: 10.1007/s13555-021-00673-y] [Reference Citation Analysis]
177 Robinson CH, Coughlin CC, Chanchlani R, Dharnidharka VR. Post-transplant malignancies in pediatric organ transplant recipients. Pediatr Transplant 2021;25:e13884. [PMID: 33111463 DOI: 10.1111/petr.13884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Wilkie MD, Lancaster J, Roland NJ, Jones TM. Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: Controversies and contemporary perspectives. Oral Oncol 2021;120:105432. [PMID: 34218060 DOI: 10.1016/j.oraloncology.2021.105432] [Reference Citation Analysis]
179 Karia PS, Morgan FC, Califano JA, Schmults CD. Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual. JAMA Dermatol 2018;154:175-81. [PMID: 29261835 DOI: 10.1001/jamadermatol.2017.3960] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
180 Usuda K, Iwai S, Yamagata A, Sekimura A, Motono N, Nakada S, Uramoto H. Unusual local and distant metastases after complete resection of roentgenographically occult squamous cell carcinoma. Gen Thorac Cardiovasc Surg 2021;69:133-6. [PMID: 32591964 DOI: 10.1007/s11748-020-01420-4] [Reference Citation Analysis]
181 Pêtre A, Pommier P, Brahmi T, Chabaud S, King S, Fayette J, Neidhart E, Amini-adle M. Benefit from adjuvant radiotherapy according to the number of risk factors in cutaneous squamous cell carcinoma. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.01.015] [Reference Citation Analysis]
182 Venables ZC, Autier P, Nijsten T, Wong KF, Langan SM, Rous B, Broggio J, Harwood C, Henson K, Proby CM, Rashbass J, Leigh IM. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England. JAMA Dermatol 2019;155:298-306. [PMID: 30484823 DOI: 10.1001/jamadermatol.2018.4219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
183 Asarkar A, Bundrick P, Nathan CO. When Should Parotidectomy and a Neck Dissection Be Performed in Cutaneous SCC of the Head and Neck? Laryngoscope 2019;129:535-6. [PMID: 30194846 DOI: 10.1002/lary.27274] [Reference Citation Analysis]
184 Tanamal PJ, Geng CX, Nijhawan RI, Wynings E, Balachandra S, Myers LL, Tillman BN, Day AT. Oncologic outcomes in primary squamous cell carcinoma of the auricle: a retrospective cohort analysis. Eur Arch Otorhinolaryngol 2021. [PMID: 33956206 DOI: 10.1007/s00405-021-06763-z] [Reference Citation Analysis]
185 Rahimi-Nedjat RK, Tuettenberg A, Sagheb K, Loquai C, Rybczynski B, Grabbe S, Walter C, Al-Nawas B. Factors accelerating recurrences and secondary tumors in cutaneous squamous cell carcinoma. J Craniomaxillofac Surg 2021;49:317-22. [PMID: 33608200 DOI: 10.1016/j.jcms.2021.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Ma JH, Wu A, Veness M, Estall V, Hong A, Borg M, James C, Ibbetson J, Ooi C, Weightman W, McColl I, Hamann I, Grieve N, Ozluer S, Salmon P, Nikitins M, Caplash Y, Marshall N, Edwards T, Patterson I, Selva D, Huilgol SC. In-Transit Metastasis From Squamous Cell Carcinoma. Dermatol Surg 2016;42:1285-92. [PMID: 27598442 DOI: 10.1097/DSS.0000000000000864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
187 Kejner AE, Harris BN, Patel R, Mcmullen C, Weir J, Dahshan BA, Carroll WR, Gillespie MB. Management of the parotid for high-risk cutaneous squamous cell carcinoma: A review from the salivary section of the American Head and Neck Society. American Journal of Otolaryngology 2022. [DOI: 10.1016/j.amjoto.2022.103374] [Reference Citation Analysis]
188 Quinn PL, Kim JK, Prasath V, Panse N, Knackstedt TJ, Chokshi RJ. Sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma using the Brigham and Women's staging system: a cost analysis. Arch Dermatol Res 2022. [PMID: 35303163 DOI: 10.1007/s00403-022-02347-x] [Reference Citation Analysis]
189 Nash J, Shahwan KT, Chung C, Abidi N, Gokun Y, Pan X, Carr DR. Grading of differentiation in cutaneous squamous cell carcinoma: Evaluation of interrater and intrarater reliability. Journal of the American Academy of Dermatology 2021. [DOI: 10.1016/j.jaad.2021.12.015] [Reference Citation Analysis]
190 Kim JYS, Kozlow JH, Mittal B, Moyer J, Olenecki T, Rodgers P; Work Group., Invited Reviewers. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol 2018;78:560-78. [PMID: 29331386 DOI: 10.1016/j.jaad.2017.10.007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 95] [Article Influence: 29.3] [Reference Citation Analysis]
191 Fix W, Etzkorn JR, Shin TM, Howe N, Bhatt M, Sobanko JF, Miller CJ. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors. J Am Acad Dermatol 2021;85:409-18. [PMID: 30458206 DOI: 10.1016/j.jaad.2018.11.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
192 Caparrotti F, Troussier I, Ali A, Zilli T. Localized Non-melanoma Skin Cancer: Risk Factors of Post-surgical Relapse and Role of Postoperative Radiotherapy. Curr Treat Options Oncol 2020;21:97. [PMID: 33034759 DOI: 10.1007/s11864-020-00792-2] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Xie M, Yu J, Li L, Jia R, Song X, Wang Y, Fan X. Nomogram for Preoperative Estimation of Orbit Invasion Risk in Periocular Squamous Cell Carcinoma. Front Oncol 2020;10:564. [PMID: 32426276 DOI: 10.3389/fonc.2020.00564] [Reference Citation Analysis]
194 Litchman GH, Fitzgerald AL, Kurley SJ, Cook RW, Rigel DS. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. Curr Med Res Opin 2020;36:1295-300. [PMID: 32372702 DOI: 10.1080/03007995.2020.1763283] [Reference Citation Analysis]
195 Varki V, Ioffe OB, Bentzen SM, Heath J, Cellini A, Feliciano J, Zandberg DP. PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma. Cancer Immunol Immunother 2018;67:805-14. [PMID: 29484464 DOI: 10.1007/s00262-018-2138-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
196 Pyne JH, Myint E, Clark SP, Barr EM, Hou R. Early invasive squamous cell carcinoma recurrence rates: A study examining surgical margins, tumor surface diameter, invasion depth, and grade of differentiation in 1296 cases over 9 years. J Cutan Pathol 2019;46:111-6. [PMID: 30421522 DOI: 10.1111/cup.13392] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Cordel N, Bonnecarrère L, Tressières B. Squamous cell carcinoma in the Afro-Caribbean community: an 11-year retrospective study. J Eur Acad Dermatol Venereol 2017;31:1462-7. [PMID: 28543620 DOI: 10.1111/jdv.14348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
198 van Dam V, Trinh XB, An B, Julien L. Extra-anogenital giant cutaneous squamous cell carcinomas require multidisciplinary management. Cancer Treat Res Commun 2021;28:100413. [PMID: 34126577 DOI: 10.1016/j.ctarc.2021.100413] [Reference Citation Analysis]
199 Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. Cancer 2020;126:3900-6. [PMID: 32478867 DOI: 10.1002/cncr.32969] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
200 Gu X, Xie M, Luo Y, Song X, Xu S, Fan X. Diffuse pattern, orbital invasion, perineural invasion and Ki-67 are associated with nodal metastasis in patients with eyelid sebaceous carcinoma. Br J Ophthalmol. [DOI: 10.1136/bjophthalmol-2021-320547] [Reference Citation Analysis]
201 Jambusaria-Pahlajani A, Karia PS, Schmults CD. Risk Factors Party Together: The Role of Perineural Invasion and Desmoplasia in Cutaneous Squamous Cell Carcinoma Prognosis. J Invest Dermatol 2020;140:1893-4. [PMID: 32972522 DOI: 10.1016/j.jid.2020.05.094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Zeng S, Fu L, Zhou P, Ling H. Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis. PLoS One 2020;15:e0239586. [PMID: 32991600 DOI: 10.1371/journal.pone.0239586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
203 Oh Y, Kim J, Zheng Z, Kim SK, Chung KY, Roh MR. Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients. J Dermatol 2020;47:72-7. [PMID: 31674043 DOI: 10.1111/1346-8138.15129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
204 Slater NA, Googe PB. PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis. J Cutan Pathol 2016;43:663-70. [PMID: 27153517 DOI: 10.1111/cup.12728] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
205 Pyne JH, Myint E, Clark SP, Clifopoulos C, Fishburn P, Gorji M, Hou R. Squamous cell carcinoma: pain as a clue to increased tumour diameter, increased invasion depth, the grade of differentiation, acantholysis and perineural invasion. Clin Exp Dermatol 2020;45:180-6. [DOI: 10.1111/ced.14066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Genders RE, Weijns ME, Dekkers OM, Plasmeijer EI. Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2019;33:828-41. [PMID: 30793804 DOI: 10.1111/jdv.15396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]